BXP, Inc. (NYSE: BXP) announced its Investor Day on September 8, 2025, in New York. Owen Thomas, Chairman & CEO, will lead discussions covering BXP's strategies, operations, and financial matters. A live webcast will be available.

Labor Day protests organized by One Fair Wage across multiple U.S. cities criticized President Trump and advocated for a living wage. Demonstrations in Chicago, New York, Washington D.C., and San Francisco drew large crowds voicing concerns about economic inequality and political issues.

Miklos Ringbauer of MiklosCPA discusses the financial stress faced by self-employed retirees experiencing unexpected income loss. Experts offer strategies for adapting to reduced income, including budget adjustments, resilience building, and exploring alternative income streams.

Bybit's WSOT 2025 main competition, boasting an $8 million prize pool, has begun. Participation quadrupled from last year, with over 1,400 teams and 350,000 individuals competing. The competition aims to make crypto trading more accessible.

PrimeXBT, a global multi-asset broker, unveiled its new "Empowering Traders to Succeed" campaign. The initiative focuses on trader autonomy and platform improvements designed to enhance trading performance and long-term success. It builds on PrimeXBT's commitment to a client-first approach.

Primary Hydrogen Corp. (TSXV:HDRO) has started Phase 2 exploration at its Hopkins Project in Ontario, focusing on natural hydrogen and rare earth elements. Norda Stelo is conducting the sampling program, with results expected in about six weeks. This builds on previous work at the site.

Bonerge and TECH-INNO Health's MitoYouth® Urolithin A received approval from China's NMPA as a new cosmetic ingredient. This allows for the development of skincare products leveraging circadian rhythm science, offering a novel approach to anti-aging. The ingredient's dual application in oral supplements and topical products further expands its potential.

Singer Katy Perry testified in a legal battle involving the sale of a <strong$15 million Montecito mansion to 1-800-Flowers founder Carl Westcott. The dispute involves the sale's validity and financial implications for Perry and her former fiancé, Orlando Bloom.

Expert Consumers named HP's All-In Plan the best printer subscription of 2025. The plan offers a new printer, automatic ink and optional paper delivery, 24/7 support, and flexible monthly pricing starting at $7.99. This reflects a growing preference for subscription services.

NIO Inc. (NIO) announced its second-quarter 2025 results, reporting increased vehicle deliveries and total revenue. William Bin Li, CEO, highlighted strong demand for new models, projecting record third-quarter deliveries.

Hacksaw Gaming and William Hill have significantly expanded their partnership. William Hill will now offer a wider range of Hacksaw Gaming's slots, enhancing its casino game selection. This collaboration underscores the growing demand for high-quality online slots in the UK market.

BearingPoint and ABeam Consulting formed a US joint venture, BearingPoint NA LLC, headquartered in Chicago. This expands their global partnership, focusing on end-to-end SAP consulting and implementation across the Americas. The venture leverages both firms' expertise and resources.

SAP announced enhanced SAP Sovereign Cloud offerings, boosting European digital sovereignty and AI innovation. New deployment models provide greater control and compliance, aligning with Saueressig's vision for European AI leadership. This significant investment underscores SAP's commitment to European digital autonomy.

Hemex AG, a European CRO, announced a global alliance expanding its reach. The alliance, including Kitsa USA and Shankus Hospitals, offers comprehensive clinical trial solutions with faster recruitment and regulatory alignment. This boosts efficiency in global clinical development.

Vincent Ossipow resigned from BioInvent International AB's board of directors, effective immediately. The company expressed gratitude for his contributions, highlighting his guidance during periods of growth and transformation. BioInvent's board remains fully functional.